PuriBlood Medical Co (ROCO:6847) EV-to-EBITDA : 387.01 (As of May. 22, 2025)

PuriBlood Medical Co EV-to-EBITDA Chart

PuriBlood Medical Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBITDA	Get a 7-Day Free Trial							72.46	-	-34.13	-	448.56

Competitive Comparison of PuriBlood Medical Co's EV-to-EBITDA

For the Diagnostics & Research subindustry, PuriBlood Medical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PuriBlood Medical Co's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's EV-to-EBITDA falls into.

PuriBlood Medical Co EV-to-EBITDA Calculation

PuriBlood Medical Co's EV-to-EBITDA for today is calculated as:

PuriBlood Medical Co's current Enterprise Value is NT$1,194.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PuriBlood Medical Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was NT$3.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PuriBlood Medical Co  (ROCO:6847) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

PuriBlood Medical Co's PE Ratio (TTM) for today is calculated as:

PuriBlood Medical Co's share price for today is NT$86.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PuriBlood Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-0.380.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

PuriBlood Medical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

PuriBlood Medical Co Business Description